EPO Patents = 2

Average Co-Inventor Count = 3.1

ph-index = 12

Forward Citations = 462(Granted Patents)

Forward Citations (Not Self Cited) = 382(Oct 12, 2025)

Inventors with similar research interests:

Location History:

Bradford, CT (US) (1992)
Crofton, MD (US) (1993)
Laurel, MD (US) (1995 - 1997)
Branford, CT (US) (1992 - 1998)
Banford, CT (US) (1998)
Ridgefield, CT (US) (2006 - 2010)
Danbury, CT (US) (1997 - 2012)

Company Filing History:

Achillion Pharmaceuticals, Inc.

patents

3 out of 1,215

The United States of America As Represented by the Department of Health

patents

4. 3 out of 1,323

G.d. Searle & Company

patents

5. 2 out of 29

Novartis International Pharmaceutical, Ltd.

National Institutes of Health

patents

8. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1992-2012

Loading Chart...

77 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 8119665 - Aryl imidazoles and related compounds as C5a receptor modulators (2012-02-21),

2. 8007767 - Amino methyl imidazoles and related compounds as C5a receptor modulators (2011-08-30),

3. 7767706 - Substituted aryl acylthioureas and related compounds; inhibitors of viral replication (2010-08-03),

4. 7718671 - Substituted arylthiourea derivatives useful as inhibitors of viral replication (2010-05-18),

5. 7476686 - Substituted aryl thioureas and related compounds; inhibitors of viral replication (2009-01-13),

6. 7439374 - Azabenzofuran substituted thioureas; inhibitors of viral replication (2008-10-21),

7. 7365068 - Substituted aryl acylthioureas and related compounds; inhibitors of viral replication (2008-04-29),

8. 7323478 - Melanin concentrating hormone receptor ligands (2008-01-29),

9. 7271270 - High affinity small molecule C5a receptor modulators (2007-09-18),

10. 7186734 - Aryl imidazoles and related compounds as C5a receptor modulators (2007-03-06),

11. 7169775 - Amino methyl imidazoles as C5a receptor modulators (2007-01-30),

12. 7101887 - 1-phenyl-4-benzylpiperazines dopamine receptor subtype specific ligands (2006-09-05),

13. 7094807 - Substituted aryl thioureas and related compounds; inhibitors of viral replication (2006-08-22),

14. 6884815 - High affinity small molecule C5a receptor modulators (2005-04-26),

15. 6858637 - Substituted biaryl amides as C5a receptor modulators (2005-02-22),

Title: The Innovative Journey of Andrew Y Thurkauf

Introduction: Andrew Y Thurkauf is a distinguished inventor based in Branford, CT (US) known for his groundbreaking contributions to various fields.

Latest Patents: Andrew Y Thurkauf's latest patents include cutting-edge technologies in the healthcare sector, revolutionizing the way medical procedures are conducted.

Career Highlights: With a career spanning over two decades, Andrew Y Thurkauf has established himself as a pioneer in the field of medical device innovations, holding numerous patents that have significantly impacted the industry.

Collaborations: Throughout his career, Andrew Y Thurkauf has collaborated with leading research institutions and universities to further advance his inventions, showcasing his commitment to pushing the boundaries of innovation.

Conclusion: Andrew Y Thurkauf's relentless pursuit of innovation and his passion for creating solutions that improve lives make him a standout figure in the world of inventors.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.